https://www.selleckchem.com/pr....oducts/1-thioglycero
Distal bypass (D is the optimal treatment for patients with critical limb ischemia (CLI). However, effectiveness of DB for patients with intermittent claudication (IC) remains uncertain. This study aimed to analyze long-term results of DB for IC patients (IC-D compared with those of DB for CLI patients (CLI-D. Patients undergoing DB from January 2009 to July 2018 at a single institution were retrospectively reviewed. Operative details, primary and secondary patency, amputation free survival rate (AFS), and long-term exercis
Like
Comment
Share
